Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C

被引:7
|
作者
Denise C Paranaguá-Vezozzo [1 ]
Adriana Andrade [1 ]
Daniel F C Mazo [1 ,2 ]
Vinicius Nunes [1 ]
Ana L Guedes [1 ]
Taisa G Ragazzo [1 ]
Renata Moutinho [1 ]
Lucas S Nacif [1 ]
Suzane K Ono [1 ]
Venancio A F Alves [3 ]
Flair J Carrilho [1 ]
机构
[1] Division of Clinical Gastroenterology and Hepatology,Hospital das Clínicas,Department of Gastroenterology,University of S?o Paulo School of Medicine
[2] Division of Gastroenterology,School of Medical Sciences,State University of Campinas
[3] Department of Pathology,University of S?o Paulo School of Medicine
关键词
Elastography; Serum markers; Hepatitis C virus; Liver stiffness; Liver biopsy;
D O I
暂无
中图分类号
R512.63 []; R575.2 [肝硬变];
学科分类号
1002 ; 100201 ; 100401 ;
摘要
AIM To determine the sensitivity and specificity of liver stiffness measurement(LSM) and serum markers(SM) for liver fibrosis evaluation in chronic hepatitis C.METHODS Between 2012 and 2014,81 consecutive hepatitis C virus(HCV) patients had METAVIR score from liver biopsy compared with concurrent results from LSM [transient elastography(TE) [FibroS can;/ARFI technology(Virtual Touch;)] and SM [FIB-4/aspartate aminotransferase-toplatelet ratio index(APRI)].The diagnostic performance of these tests was assessed using receiver operating characteristic curves.The optimal cut-off levels of each test were chosen to define fibrosis stages F ≥ 2,F ≥ 3 and F = 4.The Kappa index set the concordance analysis.RESULTS Fifty point six percent were female and the median age was 51 years(30-78).Fifty-six patients(70%) weretreatment-na?ve.The optimal cut-off values for predicting F ≥ 2 stage fibrosis assessed by TE were 6.6 kP a,for acoustic radiation force impulse(ARFI) 1.22 m/s,for APRI 0.75 and for FIB-4 1.47.For F ≥ 3 TE was 8.9 kP a,ARFI was 1.48 m/s,APRI was 0.75,and FIB-4 was 2.For F = 4,TE was 12.2 kP a,ARFI was 1.77 m/s,APRI was 1.46,and FIB-4 was 3.91.The APRI could not distinguish between F2 and F3,P = 0.92.The negative predictive value for F = 4 for TE and ARFI was 100%.Kappa index values for F ≥ 3 METAVIR score for TE,ARFI and FIB-4 were 0.687,0.606 and 0.654,respectively.This demonstrates strong concordance between all three screening methods,and moderate to strong concordance between them and APRI(Kappa index = 0.507).CONCLUSION Given the costs and accessibility of LSM methods,and the similarity with the outcomes of SM,we suggest that FIB-4 as well as TE and ARFI may be useful indicators of the degree of liver fibrosis.This is of particular importance to developing countries.
引用
收藏
页码:436 / 442
页数:7
相关论文
共 50 条
  • [1] NON-INVASIVE EVALUATION OF LIVER FIBROSIS IN CHRONIC HEPATITIS C
    Trifan, Anca
    Cojocariu, Camelia
    Sfarti, C.
    Singeap, Ana Maria
    Stanciu, C.
    [J]. MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2012, 116 (01): : 135 - 138
  • [2] Non-invasive evaluation of liver fibrosis in hepatitis C
    de Ledinghen, V.
    Poynard, T.
    Wartelle, C.
    Rosenthal, E.
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2008, 32 (03): : S90 - S95
  • [3] Non-invasive assessment of liver fibrosis in chronic hepatitis C
    Laurent Castera
    [J]. Hepatology International, 2011, 5 : 625 - 634
  • [4] Non-invasive assessment of liver fibrosis in chronic hepatitis C
    Castera, Laurent
    [J]. HEPATOLOGY INTERNATIONAL, 2011, 5 (02) : 625 - 634
  • [5] Non-invasive diagnosis of liver fibrosis in chronic hepatitis C
    Schiavon, Leonardo de Lucca
    Narciso-Schiavon, Janaina Luz
    de Carvalho-Filho, Roberto Jose
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (11) : 2854 - 2866
  • [6] Non-invasive diagnosis of liver fibrosis in chronic hepatitis C
    Leonardo de Lucca Schiavon
    Janaína Luz Narciso-Schiavon
    Roberto José de Carvalho-Filho
    [J]. World Journal of Gastroenterology, 2014, (11) : 2854 - 2866
  • [7] The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients
    Erdogan, Serpil
    Dogan, Halef Okan
    Sezer, Sevilay
    Uysal, Sema
    Ozhamam, Esra
    Kayacetin, Serra
    Koca, Yuksel
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2013, 73 (04): : 300 - 308
  • [8] Prediction of liver fibrosis progression by non-invasive tests in chronic hepatitis C: The impact of validation
    Sebastiani, Giada
    Ghali, Peter
    Wong, Phil
    Deschenes, Marc
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 (04) : 831 - 832
  • [9] Evaluation of EASL recommendation for the non-invasive diagnosis of liver fibrosis in chronic hepatitis C
    Boursier, Jerome
    de Ledinghen, Victor
    Leroy, Vincent
    Frederic, Oberti
    Fouchard-Hubert, Isabelle
    Cales, Paul
    [J]. HEPATOLOGY, 2015, 62 : 269A - 269A
  • [10] Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C?
    Ladero, Jose M.
    Cardenas, Maria C.
    Ortega, Luis
    Gonzalez-Pino, Andrea
    Cuenca, Francisca
    Morales, Cesar
    Lee-Brunner, Anna
    [J]. ANNALS OF HEPATOLOGY, 2012, 11 (05) : 648 - 651